- Home
- MKFG vs AVTE Comparison
MKFG vs AVTE Comparison
Compare MKFG & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKFG
- AVTE
- Stock Information
- Founded
- MKFG 2013
- AVTE 2018
- Country
- MKFG United States
- AVTE United States
- Employees
- MKFG N/A
- AVTE N/A
- Industry
- MKFG Retail: Computer Software & Peripheral Equipment
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- MKFG Technology
- AVTE Health Care
- Exchange
- MKFG Nasdaq
- AVTE Nasdaq
- Market Cap
- MKFG 60.6M
- AVTE 72.5M
- IPO Year
- MKFG N/A
- AVTE 2021
- Fundamental
- Price
- MKFG $4.55
- AVTE $2.51
- Analyst Decision
- MKFG Hold
- AVTE Hold
- Analyst Count
- MKFG 2
- AVTE 7
- Target Price
- MKFG $5.00
- AVTE $11.75
- AVG Volume (30 Days)
- MKFG 282.8K
- AVTE 62.5K
- Earning Date
- MKFG 03-28-2025
- AVTE 03-27-2025
- Dividend Yield
- MKFG N/A
- AVTE N/A
- EPS Growth
- MKFG N/A
- AVTE N/A
- EPS
- MKFG N/A
- AVTE N/A
- Revenue
- MKFG $85,090,000.00
- AVTE N/A
- Revenue This Year
- MKFG N/A
- AVTE N/A
- Revenue Next Year
- MKFG $9.07
- AVTE N/A
- P/E Ratio
- MKFG N/A
- AVTE N/A
- Revenue Growth
- MKFG N/A
- AVTE N/A
- 52 Week Low
- MKFG $1.57
- AVTE $1.25
- 52 Week High
- MKFG $7.80
- AVTE $30.29
- Technical
- Relative Strength Index (RSI)
- MKFG 77.25
- AVTE 51.75
- Support Level
- MKFG $4.41
- AVTE $2.45
- Resistance Level
- MKFG $4.80
- AVTE $2.56
- Average True Range (ATR)
- MKFG 0.24
- AVTE 0.08
- MACD
- MKFG 0.14
- AVTE 0.00
- Stochastic Oscillator
- MKFG 91.81
- AVTE 77.14
About MKFG Markforged Holding Corporation
Markforged Holding Corp transforms manufacturing with 3D metal and continuous carbon fiber printers capable of producing parts tough enough for the factory floor. intuitive additive manufacturing platform for modern manufacturers, bringing the power and speed of agile software development to industrial manufacturing. Composed of hardware, software and materials working as a unified platform. It operates in industries such as Aerospace, Automotive, Consumer Packaged Goods, Education and Research, Electronics Manufacturing, Energy, Federal and Defense, Industrial Equipment. The company's geographical segments include the Americas; Europe, the Middle East, Africa; and Asia-Pacific. It derives maximum revenue from Americas.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.